References
- Chari RVJ, Miller ML, Widdison WC. Antibody–drug conjugates: an emerging concept in cancer therapy. Angew Chem Int Ed Engl. 2014 Apr 7;53(15):3796–11. doi:https://doi.org/10.1002/anie.201307628.
- Peters C, Brown S. Antibody–drug conjugates as novel anti-cancer chemotherapeutics. Biosci Rep. 2015 Jun 12;35(4). doi:https://doi.org/10.1042/BSR20150089.
- Wang H, Rangan VS, Sung MC, Passmore D, Kempe T, Wang X, Thevanayagam L, Pan C, Rao C, Srinivasan M, et al. Pharmacokinetic characterization of BMS-936561, an anti-CD70 antibody-drug conjugate, in preclinical animal species and prediction of its pharmacokinetics in humans. Biopharm Drug Dispos. 2016 Mar;37(2):93–106. doi:https://doi.org/10.1002/bdd.1953.
- Polakis P. Antibody drug conjugates for cancer therapy. Pharmacol Rev. 2016 Jan;68(1):3–19. doi:https://doi.org/10.1124/pr.114.009373.
- Strop P, Delaria K, Foletti D, Witt JM, Hasa-Moreno A, Poulsen K, Casas MG, Dorywalska M, Farias S, Pios A, et al. Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading. Nat Biotechnol. 2015 Jul;33(7):694–96. doi:https://doi.org/10.1038/nbt.3274.
- Junutula JR, Raab H, Clark S, Bhakta S, Leipold DD, Weir S, Chen Y, Simpson M, Tsai SP, Dennis MS, et al. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Nat Biotechnol. 2008 Aug;26(8):925–32. doi:https://doi.org/10.1038/nbt.1480. Epub 2008 Jul 20.
- Borthwick AD, Exall AM, Haley TM, Jackson DL, Mason AM, Weingarten GG. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability. Bioorg Med Chem Lett. 2002 Jul 8;12(13):1719–22. doi:https://doi.org/10.1016/S0960-894X(02)00294-9.
- Borthwick AD, Davies DE, Ertl PF, Exall AM, Haley TM, Hart GJ, Jackson DL, Parry NR, Patikis A, Trivedi N, et al. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability. J Med Chem. 2003 Oct 9;46(21):4428–49. doi:https://doi.org/10.1021/jm030810w.
- Breitenlechner CB, Wegge T, Berillon L, Graul K, Marzenell K, Friebe WG, Thomas U, Schumacher R, Huber R, Engh RA, et al. Structure-based optimization of novel azepane derivatives as PKB inhibitors. J Med Chem. 2004 Mar 11;47(6):1375–90. doi:https://doi.org/10.1021/jm0310479.
- Dorywalska M, Dushin R, Moine L, Farias SE, Zhou D, Navaratnam T, Lui V, Hasa-Moreno A, Casas MG, Tran TT, et al. Molecular basis of valine-citrulline-PABC linker instability in site-specific ADCs and its mitigation by linker design. Mol Cancer Ther. 2016 May;15(5):958–70. doi:https://doi.org/10.1158/1535-7163.MCT-15-1004.
- Kerns EH. High throughput physicochemical profiling for drug discovery. J Pharm Sci. 2001 Nov;90(11):1838–58. doi:https://doi.org/10.1002/jps.1134.
- Kerns EH, Di L. Pharmaceutical profiling in drug discovery. Drug Discov Today. 2003 Apr 1;8(7):316–23. doi:https://doi.org/10.1016/S1359-6446(03)02649-7.
- Di L, Kerns EH. Profiling drug-like properties in discovery research. Curr Opin Chem Biol. 2003 Jun;7(3):402–08. doi:https://doi.org/10.1016/S1367-5931(03)00055-3.
- Di L, Kerns EH, Chen H, Petusky SL. Development and application of an automated solution stability assay for drug discovery. J Biomol Screen. 2006 Feb;11(1):40–47. doi:https://doi.org/10.1177/1087057105281363. Epub 2005 Oct 18.
- Xu K, Liu L, Saad OM, Baudys J, Williams L, Leipold D, Shen B, Raab H, Junutula JR, Kim A, et al. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry. Anal Biochem. 2011 May 1;412(1):56–66. doi:https://doi.org/10.1016/j.ab.2011.01.004.
- Shen BQ, Xu K, Liu L, Raab H, Bhakta S, Kenrick M, Parsons-Reponte KL, Tien J, Yu SF, Mai E, et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat Biotechnol. 2012 Jan 22;30(2):184–89. doi:https://doi.org/10.1038/nbt.2108.
- Ohri R, Bhakta S, Fourie-O’Donohue A, Dela Cruz-Chuh J, Tsai SP, Cook R, Wei B, Ng C, Wong AW, Bos AB, et al. High-throughput cysteine scanning to identify stable antibody conjugation sites for maleimide- and disulfide-based linkers. Bioconjug Chem. 2018 Feb 21;29(2):473–85. doi:https://doi.org/10.1021/acs.bioconjchem.7b00791.
- Su D, Ng C, Khosraviani M, Yu S, Cosino E, Kaur S, Xu K. Custom-designed affinity capture LC-MS F(ab′)2 assay for biotransformation assessment of site-specific antibody drug conjugates. Anal Chem. 2016 Dec 6;88(23):11340–46. doi:https://doi.org/10.1021/acs.analchem.6b03410.
- Durbin KR, Nottoli MS, Catron ND, Richwine N, Jenkins GJ. High-throughput, multispecies, parallelized plasma stability assay for the determination and characterization of antibody–drug conjugate aggregation and drug release. ACS Omega. 2017 Aug 31;2(8):4207–15. doi:https://doi.org/10.1021/acsomega.7b00452.
- Bessire AJ, Ballard TE, Charati M, Cohen J, Green M, Lam MH, Loganzo F, Nolting B, Pierce B, Puthenveetil S. Determination of antibody–drug conjugate released payload species using directed in vitro assays and mass spectrometric interrogation. Bioconjug Chem. 2016 Jul 20;27(7):1645–54. doi:https://doi.org/10.1021/acs.bioconjchem.6b00192.
- Kabat EA, Wu TT, Perry HM, Foeller C, Gottesman KS. The nomenclature used to depict the mAb attachment sites follows that Described. In: Sequences of proteins of immunological interest. Darby (PA): Diane Publishing; 1992. ISBN 094137565X.
- Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991 Sep;29(9):549–54. doi:https://doi.org/10.1515/cclm.1991.29.9.549.
- Stabler SP, Marcell PD, Podell ER, Allen RH. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem. 1987 Apr;162(1):185–96. doi:https://doi.org/10.1016/0003-2697(87)90026-1.
- Andersson A, Isaksson A, Hultberg B. Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem. 1992 Jul;38(7):1311–15. doi:https://doi.org/10.1093/clinchem/38.7.1311.
- Salazar JF, Herbeth B, Siest G, Leroy P. Stability of blood homocysteine and other thiols: EDTA or acidic citrate? Clin Chem. 1999 Nov;45(11):2016–19.
- Rossi R, Milzani A, Dalle-Donne I, Giustarini D, Lusini L, Colombo R, Di Simplicio P. Blood glutathione disulfide: in vivo factor or in vitro artifact? Clin Chem. 2002 May;48(5):742–53.
- Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem. 2012 Apr;45(6):464–69. doi:https://doi.org/10.1016/j.clinbiochem.2012.01.012.
- Powis G, DeGraw CL. N-oxide reduction by hemoglobin, cytochrome C and ferrous ions. Res Commun Chem Pathol Pharmacol. 1980 Oct;30(1):143–50.
- Lavrijsen K, van Dyck D, van Houdt J, Hendrickx J, Monbaliu J, Woestenborghs R, Meuldermans W, Heykants J. Reduction of the prodrug loperamide oxide to its active drug loperamide in the gut of rats, dogs, and humans. Drug Metab Dispos. 1995 Mar;23(3):354–62.
- Kitamura S, Terada A, Inoue N, Kamio H, Ohta S, Tatsumi K. Quinone-dependent tertiary amine N-oxide reduction in rat blood. Biol Pharm Bull. 1998 Dec;21(12):1344–47. doi:https://doi.org/10.1248/bpb.21.1344.
- Kitamura S, Takekawa K, Sugihara K, Ohta S. Nonenzymatic reduction of N-hydroxy-2- acetylaminofluorene to 2-acetylaminofluorene by heme in the presence of hydroquinones. J Health Sci. 2000;46(1):66–69. doi:https://doi.org/10.1248/jhs.46.66.
- Sugihara K, Kitamura S, Ohta S, Tatsumi K. Reduction of hydroxamic acids to the corresponding amides catalyzed by rabbit blood. Xenobiotica. 2000 May;30(5):457–67. doi:https://doi.org/10.1080/004982500237479.
- Dorywalska M, Strop P, Melton-Witt JA, Hasa-Moreno A, Farias SE, Galindo Casas M, Delaria K, Lui V, Poulsen K, Sutton J, et al. Site-dependent degradation of a non-cleavable auristatin-based linker-payload in rodent plasma and its effect on ADC efficacy. PLoS One. 2015 Jul 10;10(7):e0132282. doi:https://doi.org/10.1371/journal.pone.0132282.
- Dorywalska M, Strop P, Melton-Witt JA, Hasa-Moreno A, Farias SE, Galindo Casas M, Delaria K, Lui V, Poulsen K, Loo C, et al. Effect of attachment site on stability of cleavable antibody drug conjugates. Bioconjug Chem. 2015 Apr 15;26(4):650–59. doi:https://doi.org/10.1021/bc5005747.
- Bahar FG, Ohura K, Ogihara T, Imai TJ. Species difference of esterase expression and hydrolase activity in plasma. J Pharm Sci. 2012 Oct;101(10):3979–88. doi:https://doi.org/10.1002/jps.23258.